Literature DB >> 18987367

Drug development for neglected diseases - the trouble with FDA review vouchers.

Aaron S Kesselheim1.   

Abstract

Mesh：

Year:  2008        PMID： 18987367     DOI： 10.1056/NEJMp0806684

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.

Authors:  Aaron S Kesselheim
Journal:  Milbank Q       Date:  2011-09       Impact factor: 4.911

2.  One step forward, one step sideways? Expanding research capacity for neglected diseases.

Authors:  Joel Lexchin
Journal:  BMC Int Health Hum Rights       Date:  2010-07-14

Review 3.  Driving a decade of change: HIV/AIDS, patents and access to medicines for all.

Authors:  Ellen 't Hoen; Jonathan Berger; Alexandra Calmy; Suerie Moon
Journal:  J Int AIDS Soc       Date:  2011-03-27       Impact factor: 6.707

Review 4.  A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics.

Authors:  Matthew J Renwick; David M Brogan; Elias Mossialos
Journal:  J Antibiot (Tokyo)       Date:  2015-10-14       Impact factor: 2.649

5.  Neglected Population, Neglected Right: Children Living with HIV and the Right to Science.

Authors:  Michael L Scanlon; Gillian MacNaughton; Courtenay Sprague
Journal:  Health Hum Rights       Date:  2017-12

Review 6.  Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most.

Authors:  Temmy Sunyoto; Julien Potet; Marleen Boelaert
Journal:  BMJ Glob Health       Date:  2018-05-03

7.  Is the priority review voucher program stimulating new drug development for tropical diseases?

Authors:  Kirk W Kerr; Thomas C Henry; Kathleen L Miller
Journal:  PLoS Negl Trop Dis       Date:  2018-08-09

Review 8.  The impact of the US priority review voucher on private-sector investment in global health research and development.

Authors:  Andrew S Robertson; Rianna Stefanakis; Don Joseph; Melinda Moree
Journal:  PLoS Negl Trop Dis       Date:  2012-08-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.